Currently, there are 141.43M common shares owned by the public and among those 138.38M shares have been available to trade.
The company’s stock has a 5-day price change of 13.74% and -28.69% over the past three months. MGNI shares are trading -30.84% year to date (YTD), with the 12-month market performance up to 28.32% higher. It has a 12-month low price of $8.22 and touched a high of $21.29 over the same period. MGNI has an average intraday trading volume of 2.95 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 1.56%, -20.95%, and -23.61% respectively.
Institutional ownership of Magnite Inc (NASDAQ: MGNI) shares accounts for 87.68% of the company’s 141.43M shares outstanding.
It has a market capitalization of $1.57B and a beta (3y monthly) value of 2.61. The stock’s trailing 12-month PE ratio is 79.38, while the earnings-per-share (ttm) stands at $0.14. Price movements for the stock have been influenced by the stock’s volatility, which stands at 7.86% over the week and 9.06% over the month.
Analysts forecast that Magnite Inc (MGNI) will achieve an EPS of 0.06 for the current quarter, 0.18 for the next quarter and 1.1 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.03 while analysts give the company a high EPS estimate of 0.03. Comparatively, EPS for the current quarter was 0.05 a year ago. Earnings per share for the fiscal year are expected to increase by 29.40%, and 21.90% over the next financial year.
Looking at the support for the MGNI, a number of firms have released research notes about the stock. Needham stated their Buy rating for the stock in a research note on December 05, 2024, with the firm’s price target at $17-$20. Scotiabank coverage for the Magnite Inc (MGNI) stock in a research note released on December 05, 2024 offered a Sector Outperform rating with a price target of $22. Wells Fargo was of a view on October 29, 2024 that the stock is Equal Weight, while Lake Street gave the stock Buy rating on July 25, 2024, issuing a price target of $21. Wolfe Research on their part issued Outperform rating on July 16, 2024.
